Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,319 papers from all fields of science
Search
Sign In
Create Free Account
tumor necrosis factor therapy
Known as:
therapy, TNF
, therapy, tumor necrosis factor
, tnf therapy
A biological therapy that involves the use of anti-tumor necrosis factor antagonists. It results in the inhibition of tumor necrosis factor and the…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Immunotherapy
cytokine therapy
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Predictors of Switching Anti-Tumor Necrosis Factor Therapy in Patients with Ankylosing Spondylitis
Jeong-Won Lee
,
Ji-Hyoun Kang
,
+7 authors
Shin-Seok Lee
PLoS ONE
2015
Corpus ID: 8530051
The aim of this study was to investigate the potential predictors of switching tumor necrosis factor (TNF)-α inhibitors in Korean…
Expand
2015
2015
A Randomized Trial Comparing Disease Activity Measures for the Assessment and Prediction of Response in Rheumatoid Arthritis Patients Initiating Certolizumab Pegol
J. Curtis
,
M. Churchill
,
+6 authors
Y. Yazici
Arthritis & Rheumatology
2015
Corpus ID: 18720348
The aim of the Patient/Physician Reported Efficacy Determination In Clinical Practice Trial (PREDICT; ClinicalTrials identifier…
Expand
Review
2013
Review
2013
Risk of nocardial infections with anti-tumor necrosis factor therapy.
T. Ali
,
A. Chakraburtty
,
Sultan Mahmood
,
M. Bronze
American Journal of the Medical Sciences
2013
Corpus ID: 205748718
Anti-tumor necrosis factor (anti-TNF) therapy is beneficial in the management of many chronic immune-mediated inflammatory…
Expand
2012
2012
Significance of sex in achieving sustained remission in the consortium of rheumatology researchers of north america cohort of rheumatoid arthritis patients
D. Jawaheer
,
S. Messing
,
+6 authors
D. Furst
Arthritis care & research
2012
Corpus ID: 15163054
To determine whether men with rheumatoid arthritis (RA) are more likely to achieve remission compared to women.
2011
2011
Regression of endometrial autografts in a rat model of endometriosis treated with etanercept.
M. Islimye
,
S. Kılıc
,
E. Zulfikaroglu
,
Onur Topcu
,
S. Zergeroğlu
,
S. Batıoğlu
European Journal of Obstetrics, Gynecology, and…
2011
Corpus ID: 39485319
Review
2010
Review
2010
Review: Anti-tumor necrosis factor therapy and influenza: keeping it in perspective
M. Shale
,
M. Czub
,
G. Kaplan
,
R. Panaccione
,
Subrata Ghosh
Therapeutic Advances in Gastroenterology
2010
Corpus ID: 24549796
The association of opportunistic infections in the context of anti-tumor necrosis factor (TNF) antibody therapies have attracted…
Expand
Highly Cited
2008
Highly Cited
2008
Increased cortisol relative to adrenocorticotropic hormone predicts improvement during anti-tumor necrosis factor therapy in rheumatoid arthritis.
R. Straub
,
G. Pongratz
,
+10 authors
P. Sarzi-Puttini
Arthritis & Rheumatism
2008
Corpus ID: 36222352
OBJECTIVE Some patients with chronic inflammatory diseases such as rheumatoid arthritis (RA) improve rapidly from anti-tumor…
Expand
Review
2008
Review
2008
Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results.
Y. Braun-Moscovici
,
D. Markovits
,
A. Rozin
,
K. Toledano
,
A. Nahir
,
A. Balbir-Gurman
The Israel Medical Association journal : IMAJ
2008
Corpus ID: 19720584
BACKGROUND Infliximab and etanercept have been included in the Israeli national list of health services since 2002 for rheumatoid…
Expand
2005
2005
Sex hormone concentrations in patients with rheumatoid arthritis are not normalized during 12 weeks of anti-tumor necrosis factor therapy.
R. Straub
,
P. Härle
,
F. Atzeni
,
C. Weidler
,
M. Cutolo
,
P. Sarzi-Puttini
Journal of Rheumatology
2005
Corpus ID: 37983276
OBJECTIVE Androgens such as dehydroepiandrosterone sulfate (DHEAS) and testosterone are markedly lower in postmenopausal women…
Expand
2005
2005
Retrospective study of the costs of care during the first year of therapy with etanercept or infliximab among patients aged > or =65 years with rheumatoid arthritis.
D. Weycker
,
E. Yu
,
J. Woolley
,
G. Oster
Clinical Therapeutics
2005
Corpus ID: 27166853
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE